A5005000329- Substance Abuse Treatment and Outcomes
- Cannabis and Cannabinoid Research
- Digital Mental Health Interventions
- Superconducting Materials and Applications
- Prenatal Substance Exposure Effects
- Hepatitis C virus research
- Hepatitis B Virus Studies
- Immune Cell Function and Interaction
- Telemedicine and Telehealth Implementation
- Mental Health Treatment and Access
- Homelessness and Social Issues
- Mobile Health and mHealth Applications
- Non-Destructive Testing Techniques
- Frequency Control in Power Systems
- Viral Infections and Outbreaks Research
- COVID-19 Digital Contact Tracing
- Magnetic Field Sensors Techniques
- Influenza Virus Research Studies
- Health Policy Implementation Science
- Opioid Use Disorder Treatment
- Magnetic Properties and Applications
- Vaccine Coverage and Hesitancy
- COVID-19 Clinical Research Studies
- Bipolar Disorder and Treatment
- COVID-19 and Mental Health
Sydney Local Health District
2018-2024
Westmead Institute
2022-2024
Westmead Institute for Medical Research
2018-2024
Westmead Hospital
2018-2024
The University of Sydney
2018-2024
Creative Research Enterprises (United States)
2018
Croydon University Hospital
2018
National Centre for Immunisation Research & Surveillance
2018
Children's Hospital at Westmead
2018
The University of Melbourne
2013
There are no effective medications for treating dependence on cannabis.To examine the safety and efficacy of nabiximols in treatment patients with cannabis dependence.This parallel double-blind randomized clinical trial comparing placebo a 12-week, multisite outpatient study recruited participants from February 3, 2016, to June 14, 2017, at 4 specialist alcohol drug services New South Wales, Australia. Participants had (as defined by International Statistical Classification Diseases Related...
Abstract Gaps in hepatitis C virus (HCV) testing, diagnosis, liver disease assessment and treatment uptake among people who inject drugs (PWID) persist. We aimed to describe the cascade of HCV care PWID Australia, prior following unrestricted access direct‐acting antiviral (DAA) treatment. Participants enrolled an observational cohort study between 2014 2018 provided fingerstick whole‐blood samples for dried blood spot, Xpert Viral Load venepuncture samples. underwent transient elastography...
An Electric Power Research Institute sponsored study of superconducting, central-station turbine-generators 300 and 1200 MVA rating has been completed at General Electric. A unique construction concept is used for the superconducting field winding. The goal this to ensure that winding can be energized current flux density predicted by superconductor short-sample data, without "training" instabilities frequently encountered in large coils. remainder rotor components includes an aluminum...
Take-home naloxone (THN) interventions are an effective response to preventing overdose deaths, however uptake across Australia remains limited. This project designed, implemented and evaluated a model of care targeting opioid users attending alcohol other drug (AOD) treatment, needle syringe programs (NSP) related health services people who inject drugs.Service providers, consumers regulators collaboratively designed THN brief intervention (ORTHN, Overdose Response with Take-Home Naloxone)...
The Australian Treatment Outcomes Profile (ATOP) is a brief instrument measuring recent substance use, risk profile and general health wellbeing among clients attending alcohol other drug (AoD) treatment services. This study evaluates the ATOP for concurrent validity, inter-rater test-re-test reliability opioid groups.For validity reliability, participants completed an with clinician plus standardized questionnaires (time-line follow-back, Opiate Index, Kessler-10, 12-item Short Form Survey,...
There is increasing interest and evidence for the use of cannabinoid medications in treatment cannabis disorder, but little examination correlates successful treatment. This paper a secondary analysis randomised placebo-controlled trial nabiximols disorder (CUD), aiming to identify which client characteristics impact engagement outcomes.
Background: In this study, we determined the impact of COVID-19 pandemic on Western Sydney patients with substance use disorders (SUD) by comparing emergency department (ED) admission rates before and after onset rollout vaccination. Methods: ED data for SUD were retrieved from local electronic medical record (eMR) hospital central database. collected 25 January to July 2019 (before pandemic) compared 2020 (early pandemic). reasons categorised based presenting complaints diagnoses. Results:...
Abstract Introduction and Aims The Australian Treatment Outcomes Profile (ATOP) was developed as a clinical tool for monitoring the substance use, health wellbeing of clients in alcohol other drug treatment. This is first psychometric validation ATOP cannabis‐dependent treatment population. Design Methods A total 128 individuals with cannabis dependence enrolled an outpatient randomised controlled trial were administered gold‐standard questionnaires once by clinicians researchers at...
Although digital computers may be used to study power systems, there is still scope for the employment of model systems; and in these, most difficult items are alternators, because mechanical electrical parameters must both scaled correctly. Much has been written on modelling, it clear that apparently attractive technique exact geometric scaling unacceptable unless some basic such as mass density, resistivity permeability given significantly changed values model. Unfortunately, required...
Abstract Background People with substance use disorder are at high risk of harms from COVID-19 infection. Vaccine hesitancy is common in this population and compounds pre-existing barriers to accessing health care. A drug alcohol service Sydney, Australia introduced strategies enhance vaccination people receiving opioid agonist treatment (OAT). We report outcomes staff experiences this. Methods This mixed methods study (i) retrospectively evaluated vaccine uptake OAT (ii) explored...
Abstract Introduction The aim of this paper was to examine the client and psychosocial characteristics associated with polydrug use in patients alcohol misuse as their primary drug concern (PDC) seeking treatment from substance centres. Methods Self‐report surveys were undertaken clients attending 1 34 community‐based centres across Australia PDC. Survey items included client's socio‐demographic characteristics, level dependence, other drugs including tobacco, health wellbeing factors...
<sec> <title>BACKGROUND</title> The COVID-19 pandemic impacted patients with substance use disorder (SUD) more than the general population and resulted in substantially increased emergency department admissions. Routine care of attending drug health services during transitioned, telehealth being important delivering appropriate care. However, introduces unique risks such as privacy, confidentiality, data safety. Providing through may fail if legal impacts are not fully identified acted on by...